Early onset of natalizumab-related progressive multifocal leukoencephalopathy

Multiple Sclerosis Journal

Volumn 17, Issue 11, 2011, Pages 1397-1398

  Damasceno, A ^a   Von Glehn, F ^a   Martinez, A R M ^a   Longhini, A L F ^a   Deus Silva, L ^a   Brandao C O ^a   Santos, L M B ^a   Damasceno, B P ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA1 INTERFERON; GADOLINIUM; GLATIRAMER; MIRTAZAPINE; MONOCLONAL ANTIBODY; NATALIZUMAB;

ARM; ATAXIA; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG CLEARANCE; DRUG EXPOSURE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; IMMUNE SYSTEM; JC VIRUS; LETTER; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT CARE; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELAPSE; TEMPORAL LOBE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 80655128155     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511422929     Document Type: Letter

References (3)

1. Clifford DB, De Luca A, Simpson DM, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol. 2010 ; 9: 438-446
2. Schröder A, Lee DH, Hellwig K, et al. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol. 2010 ; 67: 1391-1394
3. Khatri BO, Man S, Giovannoni G, et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology. 2009 ; 72: 402-409